← SynDRA
REMINERTANT
SynDRA canonical compound SYN0011971 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | NTSR1 | NTSR2 |
|---|
| Mechanism of action | neurotensin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- NTSR1 ANTAGONIST
- Neurotensin receptor 1 antagonist
- NTSR2 FULL AGONIST
- neurotensin receptor antagonist
Cross-references
Synonyms
- Meclinertant
- Sr48692
- SR-48692
- SR48692
- 2-(((1-(7-Chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl)carbonyl)amino)tricyclo(3.3.1.1(sup 3,7))decane-2-carboxylic acid
- 2-((1-(7-Chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl)carbonylamino)tricyclo(3.3.1.1.(3.7))decan-2-carboxylic acid;2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid
- meclinertant
- 5JBP4SI96H
- meclinertantum
- RefChem:156203
- DTXCID7085851
- Meclinertant [INN]
- C32H31ClN4O5
- UNII-5JBP4SI96H
- Q6Q
- MLS006010645
- GTPL1582
- orb1706999
- SCHEMBL1650932
- SCHEMBL29376784
- CHEBI:125516
- GLXC-15298
- BDBM50248034
- MFCD03106260
- PDSP1_000642
- PDSP2_000637
- AKOS024457771
- NCGC00242503-01
- NCGC00242503-03
- AS-89650
- FM176816
- PD119349
- SMR004701645
- SR48692?
- HY-105189
- CS-0025250
- NS00068477
- E98718
- MLS-0437456.0001
Look up REMINERTANT in the interactive SynDRA portal →